Abstract
Objective To evaluate the prevalence and prognostic implications of hypoxic liver injury(HLI)in acute ST-segment elevation myocardial infarction(STEMI). Methods Patients with STEMI who had undergone primary percutaneous coronary intervention(PCI)were enrolled from January 2013 to August 2015.Patients’ medical records were reviewed and their families were interviewed via telephone to assess the outcomes. Results Of the 622 STEMI patients(aged 62(18)years, with 534 males), 37 patients(5.9%)died during the follow-up(duration: 632(495)days). These patients were older and had higher AST 625(695)U/L vs.247(236)U/L, ALT 123(133)U/L, vs.52(42)U/L, creatine kinase-myocardial band isoenzyme 248.5(407.5)ng/ml vs.184.7(197.0)ng/ml and troponin I 80.0(30.4)ng/ml vs.49.6(61.6)ng/ml from the initial tests at the hospital.Particularly, AST and ALT independently predicted all-cause mortality. Conclusions The presence of HLI is common and predicts mortality in patients with STEMI who undergo primary PCI. Key words: Transaminases; Myocardial infarction; Liver
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
